Article Information
History
- October 21, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Klodeta Kura1,2,3,*,†,
- Nyamai Mutono4,5,*,†,
- Maria-Gloria Basáñez1,2,3,
- Luc E. Coffeng6,
- S.M. Thumbi4,5,7 and
- Roy M. Anderson1,2,3
- 1London Centre for Neglected Tropical Disease Research, London, UK
- 2Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, St Mary’s Campus, Imperial College London, UK
- 3MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK
- 4Centre for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya
- 5Paul G Allen School for Global Health, Washington State University, Pullman, USA
- 6Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
- 7Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK
- ↵†Correspondence to: k.kura{at}imperial.ac.uk; mutono.nyamai{at}uonbi.ac.ke
Posted October 21, 2023.
How does treatment coverage and proportion never treated influence the success of Schistosoma mansoni elimination as a public health problem by 2030?
